The latest price target for Doximity (NYSE:DOCS) was reported by Barclays on August 21, 2026. The analyst firm set a price target for $27.00 expecting DOCS to rise to within 12 months (a possible 9.27% upside). 59 analyst firms have reported ratings in the last year.

The latest analyst rating for Doximity (NYSE:DOCS) was provided by Barclays, and Doximity maintained their equal-weight rating.

The last upgrade for Doximity Inc happened on February 9, 2026 when Canaccord Genuity raised their price target to $34. Canaccord Genuity previously had a hold for Doximity Inc.

The last downgrade for Doximity Inc happened on August 10, 2026 when Wells Fargo changed their price target from $18 to $18 for Doximity Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on August 21, 2026 so you should expect the next rating to be made available sometime around August 21, 2027.

While ratings are subjective and will change, the latest Doximity (DOCS) rating was a maintained with a price target of $20.00 to $27.00. The current price Doximity (DOCS) is trading at is $24.71, which is within the analyst’s predicted range.